Spero Therapeutics, Inc.
SPRONext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for SPRO. That does not mean none is planned.
Get an email about SPRO's next catalysts
Track Spero Therapeutics (SPRO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
SPRO Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.14 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
TBP-PI-HBr
Urinary Tract Infection
TBPM-PI-HBr
Complicated Urinary Tract Infection
Dummy Infusion
Urinary Tract Infection
SPR720
Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
TBP-PI-HBr | Phase 3 | Urinary Tract Infection | - | - |
TBPM-PI-HBr | Phase 3 | Complicated Urinary Tract Infection | - | - |
Dummy Infusion | Phase 3 | Urinary Tract Infection | - | - |
SPR720 | Phase 2 | Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) | - | - |
Frequently asked questions
What is in Spero Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Spero Therapeutics, Inc.'s (SPRO) pipeline across Phase 3, Phase 2. Its lead program is Dummy Infusion (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Spero Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Spero Therapeutics, Inc. (SPRO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track SPRO biotech catalysts?→
Add SPRO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Spero Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.